These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35413243)

  • 1. Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site.
    Zhou T; Chen L; Gorman J; Wang S; Kwon YD; Lin BC; Louder MK; Rawi R; Stancofski ED; Yang Y; Zhang B; Quigley AF; McCoy LE; Rutten L; Verrips T; Weiss RA; ; Doria-Rose NA; Shapiro L; Kwong PD
    Structure; 2022 Jun; 30(6):862-875.e4. PubMed ID: 35413243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heavy chain-only IgG2b llama antibody effects near-pan HIV-1 neutralization by recognizing a CD4-induced epitope that includes elements of coreceptor- and CD4-binding sites.
    Acharya P; Luongo TS; Georgiev IS; Matz J; Schmidt SD; Louder MK; Kessler P; Yang Y; McKee K; O'Dell S; Chen L; Baty D; Chames P; Martin L; Mascola JR; Kwong PD
    J Virol; 2013 Sep; 87(18):10173-81. PubMed ID: 23843638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11.
    Moyo T; Ereño-Orbea J; Jacob RA; Pavillet CE; Kariuki SM; Tangie EN; Julien JP; Dorfman JR
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29618644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency.
    Zhang B; Gorman J; Kwon YD; Pegu A; Chao CW; Liu T; Asokan M; Bender MF; Bylund T; Damron L; Gollapudi D; Lei P; Li Y; Liu C; Louder MK; McKee K; Olia AS; Rawi R; Schön A; Wang S; Yang ES; Yang Y; Carlton K; Doria-Rose NA; Shapiro L; Seaman MS; Mascola JR; Kwong PD
    MAbs; 2023; 15(1):2165390. PubMed ID: 36729903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop.
    Wang H; Cohen AA; Galimidi RP; Gristick HB; Jensen GJ; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7151-E7158. PubMed ID: 27799557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.
    Ingale J; Tran K; Kong L; Dey B; McKee K; Schief W; Kwong PD; Mascola JR; Wyatt RT
    J Virol; 2014 Dec; 88(24):14002-16. PubMed ID: 25253346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1.
    Xu J; Zhou T; McKee K; Zhang B; Liu C; Nazzari AF; Pegu A; Shen CH; Becker JE; Bender MF; Chan P; Changela A; Chaudhary R; Chen X; Einav T; Kwon YD; Lin BC; Louder MK; Merriam JS; Morano NC; O'Dell S; Olia AS; Rawi R; Roark RS; Stephens T; Teng IT; Tourtellott-Fogt E; Wang S; Yang ES; Shapiro L; Tsybovsky Y; Doria-Rose NA; Casellas R; Kwong PD
    Adv Sci (Weinh); 2024 Jul; 11(26):e2309268. PubMed ID: 38704686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer.
    Yang Z; Dam KA; Bridges MD; Hoffmann MAG; DeLaitsch AT; Gristick HB; Escolano A; Gautam R; Martin MA; Nussenzweig MC; Hubbell WL; Bjorkman PJ
    Nat Commun; 2022 Feb; 13(1):732. PubMed ID: 35136084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody Recognition of CD4-Induced Open HIV-1 Env Trimers.
    Yang Z; Dam KA; Gershoni JM; Zolla-Pazner S; Bjorkman PJ
    J Virol; 2022 Dec; 96(24):e0108222. PubMed ID: 36448805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer.
    Liu Q; Acharya P; Dolan MA; Zhang P; Guzzo C; Lu J; Kwon A; Gururani D; Miao H; Bylund T; Chuang GY; Druz A; Zhou T; Rice WJ; Wigge C; Carragher B; Potter CS; Kwong PD; Lusso P
    Nat Struct Mol Biol; 2017 Apr; 24(4):370-378. PubMed ID: 28218750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the neutralizing Llama V(HH) D7 and its mode of HIV-1 gp120 interaction.
    Hinz A; Lutje Hulsik D; Forsman A; Koh WW; Belrhali H; Gorlani A; de Haard H; Weiss RA; Verrips T; Weissenhorn W
    PLoS One; 2010 May; 5(5):e10482. PubMed ID: 20463957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
    Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
    J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Constraints at the Trimer Apex Stabilize the HIV-1 Envelope in a Closed, Antibody-Protected Conformation.
    Guzzo C; Zhang P; Liu Q; Kwon AL; Uddin F; Wells AI; Schmeisser H; Cimbro R; Huang J; Doria-Rose N; Schmidt SD; Dolan MA; Connors M; Mascola JR; Lusso P
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate conformations of CD4-bound HIV-1 Env heterotrimers.
    Dam KA; Fan C; Yang Z; Bjorkman PJ
    Nature; 2023 Nov; 623(7989):1017-1025. PubMed ID: 37993719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural mechanism of trimeric HIV-1 envelope glycoprotein activation.
    Tran EE; Borgnia MJ; Kuybeda O; Schauder DM; Bartesaghi A; Frank GA; Sapiro G; Milne JL; Subramaniam S
    PLoS Pathog; 2012; 8(7):e1002797. PubMed ID: 22807678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120.
    Forsman A; Beirnaert E; Aasa-Chapman MM; Hoorelbeke B; Hijazi K; Koh W; Tack V; Szynol A; Kelly C; McKnight A; Verrips T; de Haard H; Weiss RA
    J Virol; 2008 Dec; 82(24):12069-81. PubMed ID: 18842738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational Engineering of HIV-1 Env Based on Mutational Tolerance in the CD4 and PG16 Bound States.
    Heredia JD; Park J; Choi H; Gill KS; Procko E
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C.
    Strokappe N; Szynol A; Aasa-Chapman M; Gorlani A; Forsman Quigley A; Hulsik DL; Chen L; Weiss R; de Haard H; Verrips T
    PLoS One; 2012; 7(3):e33298. PubMed ID: 22438910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5.
    Hu G; Liu J; Roux KH; Taylor KA
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28539445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.